Fig. 3From: A severe case of neuro-Sjögren’s syndrome induced by pembrolizumabLine graph showing the kinetic evolution of laboratory parameters of the patient including hemoglobin (g/l), total bilirubin (μmol/l), total IgG (g/l) and erythrocyte sedimentation rate (mm/h) (x-axis showing time in months since the initiation of therapy)Back to article page